Targeted Sequencing Market is anticipated at a CAGR of 17.3% during the forecast period 2025-2035
The targeted sequencing market was estimated to be worth USD 4.1
billion globally in 2024, and a compound annual growth rate (CAGR) of 17.3% is
anticipated over the course of the forecast period. The market for targeted
sequencing is expanding as a result of growing research projects and rising
need for early disease identification. It is very useful for diagnosing rare
diseases, pharmacogenomics, and finding genetic differences for breeding
programs, agricultural enhancement, and increased crop output.
Technological
developments in sequencing are lowering the cost of sequencing and boosting its
use in research and therapeutic settings. The need for targeted sequencing is
being driven by the rising incidence of genetic diseases. The market is
expanding as a result of the growing number of research and development
initiatives worldwide.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/targeted-sequencing-market
Growth
Drivers
Significant
market growth is being driven by ongoing developments in sequencing technology,
growing clinical and research use, and the growing applications of genomics
across multiple industries. The industry is expanding rapidly due to the
significance of genomics in public health response and preparedness.
Efficiency, accuracy, and cost-effectiveness have increased due to ongoing
developments in next-generation sequencing technologies.
The need for
targeted sequencing is being driven by the increased focus on customized
medicine, which entails adjusting medical care to each patient's unique genetic
traits. It facilitates the development of tailored medicines by allowing the
detection of genetic variation linked to disease, drug responses, and treatment
results. The market is expanding considerably due to the rising incidence of
genetic disorders, autoimmune diseases, and cancer.
Segmentation
Product
Type
· Instruments
· Services
· Kits/
Panels
· Others
By
End-User
· Diagnostic
and Clinical Laboratories
· Academic
and Research Institutions
· Pharmaceutical
and Biotech Companies
· Others
By
Application
· Cancer
· Reproductive
Health
· Heredity
Diseases
· Neurological
Disorders
· Infectious
Diseases
· Rare
Diseases
· Cardiovascular
Diseases
· Others
Regional
Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key
Players
· Illumina
· Thermo
Fisher Scientific
· Qiagen
· Agilent
Technologies
· BGI
Group
· Roche
· Oxford
Nanopore Technologies
· Pacific
Biosciences
· PerkinElmer
· GenScript
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/targeted-sequencing-market
About Us: -
xResearch is a market research and consulting
organization that uses unique data, expert analysis, and new technologies to
create trusted intelligence on industries. Our research is focused on
delivering an informed and impartial view on essential market data of industry,
and it is primarily driven by an in-depth study covering the following
parameters: Market Sizing and Forecasting, Market Segmentation, Competitive
Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment